Medical Director, MDS

Position Summary The Medical Director, Movement Disorders Specialist, GDNF Program provides strategic and hands‑on clinical leadership for gene therapy programs targeting CNS movement disorders across Phase1‑3 development. This role has study‑level accountability for clinical strategy, benefit‑risk assessment, and execution, and serves as a medical leader within the organization. Job Responsibilities Drive the overall clinical development strategy in alignment with function, program team, and timelines for the GDNF gene therapy program across Phase1–3 with a specific focus on movement disorders. Serve as a Parkinson’s clinical expert in state‑of‑the‑art, randomized, double‑blind clinical trials with emphasis on maintaining the blinding status of the trial. Serve as the medical lead for clinical trial design, protocol development, and endpoint strategy for movement disorders indications. Provide medical oversight for clinical trials, ensuring patient safety, data integrity, and regulatory compliance. Lead clinical risk‑benefit assessments, including safety signal evaluation, dose‑escalation decisions, and go/no‑go recommendations. Authoring support for regulatory interactions, including FDA meetings, briefing documents, and inspection readiness activities. Oversee long‑term follow‑up (LTFU) strategies required for gene therapy products, including delayed safety monitoring and post‑treatment commitments. Guide and mentor Medical Directors and other clinical team members; contribute to clinical capability building. Partner with Clinical Operations, Biostatistics, Regulatory, and CMC to ensure integrated program execution. Present clinical strategy and data to senior leadership, governance committees, and external stakeholders. Ensure a culture of inspection readiness, quality, and continuous improvement across the clinical organization. Support the strategic vision for clinical development for the GDNF program and contribute to broader organizational clinical strategy as appropriate. Foster and maintain strong relationships with key opinion leaders (KOLs), investigators, and external scientific and clinical stakeholders. Oversee the integration of clinical development activities with cross‑functional partners, including Regulatory, CMC/Manufacturing, Commercial, and Research, to ensure seamless program advancement. Represent the organization as a clinical and scientific leader in high‑level industry forums, scientific meetings, advisory boards, and conferences. Minimum Requirements MD from an accredited U.S. medical school or equivalent international medical degree with 6+ years relevant clinical experience with Movement Disorders patients. Completion of clinical training with board certification or eligibility in Neurology or a closely related specialty with movement disorders specialization and clinical experience. Minimum of two years of industry experience or related experience in clinical development within the pharmaceutical, biotechnology, medical device, or CRO/CDMO environment. Demonstrated leadership in the design and execution of clinical trials across multiple phases, including oversight of clinical monitoring activities. Proven experience supporting FDA or global health authority inspections, audits, or formal inspection readiness initiatives. Working knowledge of GCP, regulatory requirements, and trial quality management systems. Ability to independently lead clinical programs and make program‑level medical decisions in a regulated development environment. Strong strategic leadership and cross‑functional influence. Ability to support FDA inspection readiness activities, including review of critical trial documentation, monitoring outputs, and CAPAs. Expertise in risk‑based monitoring and clinical trial quality oversight. Strong analytical judgment applied to complex clinical and safety issues. Excellent communication and executive presentation skills. Ability to operate effectively in a fast‑paced, evolving biotech environment. Proven track record of successful clinical program leadership, including advancing programs through critical development milestones. Exceptional strategic and operational planning skills, with the ability to translate long‑term vision into executable clinical plans. Strong leadership presence with the ability to influence, inspire, and align cross‑functional teams. Established professional network within the gene therapy and/or CNS development community. Understanding of market dynamics, competitive landscape, and evolving trends relevant to gene therapy and movement disorders. Preferred Qualifications Prior experience in CNS, neurology, or movement disorders clinical development. Experience leading or significantly contributing to Phase1+2 and Phase3 registrational trials for Parkinson’s disease or similar disorders. Experience in gene therapy, cell therapy, or advanced therapeutic modalities, including long‑term safety considerations. Direct experience overseeing long‑term follow‑up (LTFU) studies for gene therapy products. Experience working in rare disease or small patient population settings. Experience mentoring Medical Directors and clinical staff with non‑neurology background. Equal Opportunity Employment Statement AskBio Inc. (AskBio) is an Equal Opportunity Employer and does not discriminate against any employee or applicant for employment because of race, color, religion, gender, sexual orientation, gender identity, national origin, age, disability, veteran status or any other protected status prohibited under Federal, State or local laws. All employment decisions are based on valid job‑related requirements. If you are a qualified individual with a disability or a disabled veteran and are unable or limited in your ability to use or access our website, you may request a reasonable accommodation to express interest in a specific opening by calling us at View phone number on click.appcast.io or sending us an email at View email address on click.appcast.io. #J-18808-Ljbffr